[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Attractions in the Liquid Biopsy Market - Global

December 2018 | 100 pages | ID: A5A5337A28BEN
Bizwit Research & Consulting LLP

US$ 4,250.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. One in 5 men and one in 6 women worldwide develop cancer during their lifetime, and one in 8 men and one in 11 women die from the disease. The five-year survival rate is estimated to be 43.8 million.

The proportions of cancer deaths in Asia (57.3%) are higher than the proportions of incident cases (48.4%), because APAC compared to US and Europe, has a higher frequency of certain cancer types associated with poorer prognosis and higher mortality rates, in addition to limited access to timely diagnosis and treatment in many countries.

The market is expected to grow to 35.50 Billion USD by 2025 growing at a CAGR of 12.57%, globally. Screening and profiling sub segment are expected to have the highest market share. The report gives insights on the screening technologies, regulations and deep dives into areas such as companion diagnostics, type of sample used, end user, etc.
1. ASSUMPTIONS FOR PRIMARY/SECONDARY RESEARCH

2. CURRENCY EXCHANGE RATES

3. ABBREVIATIONS

4. INTRODUCTION – LIQUID BIOPSY MARKET

5. RECENT TRENDS

a. Technology Updates
b. Sampling Updates
c. Needs of the Customer
d. Unmet Needs

6. DRIVERS AND RESTRAINTS

7. SWOT ANALYSIS

8. SEGMENTATION OF THE LIQUID BIOPSY MARKET

a. By Type of Sample
b. By Application Area (By Disease Types)
c. By End User
d. By Region
  i. North America
  ii. Western Europe
  iii. Asia Pacific
  iv. Rest of the world

9. COMPETITION TRENDS

10. KEY RECOMMENDATIONS


More Publications